Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
Scope of the Report:
This report focuses on the Biosimilar Drug in China market. This report categorizes the market based on manufacturers, type and application.
Market Segment by Manufacturers, this report covers
CP Guojian
Biotech
Celgen
Henlius Biotech
Amgen
Eli Lilly
Novartis
Changchun High Tech
Innovent
Market Segment by Type, covers
Injection
Tablets
Others
Market Segment by Applications, can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
There are 11 Chapters to deeply display the China Biosimilar Drug market.
Chapter 1, to describe Biosimilar Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biosimilar Drug, with sales, revenue, and price of Biosimilar Drug, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4 and 5, to show the market of Biosimilar Drug by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;
Chapter 6, Biosimilar Drug market forecast, by type and application, with sales and revenue, from 2016 to 2021;
Chapter 7, to analyze the Biosimilar Drug market development potential except China, covering China, Southeast Asia, India, Latin America etc.
Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.
Frequently Asked Questions
Table Of Content
Table of Contents
China Biosimilar Drug Market by Manufacturers, Type and Application, Forecast to 2021
1 Market Overview (Market Segment, Status and Outlook)
1.1 Biosimilar Drug Introduction
1.2 China Biosimilar Drug Market Analysis by Type
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 China Biosimilar Drug Market Analysis by Applications
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.4 China Market Biosimilar Drug Overview
1.4.1 China Biosimilar Drug Development Status and Outlook
1.4.2 Market Opportunities
1.4.3 Market Risk
1.4.4 Market Driving Force
2 Manufacturers Profiles
2.1 CP Guojian
2.1.1 Business Overview
2.1.2 Biosimilar Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.2 CP Guojian Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.2 Biotech
2.2.1 Business Overview
2.2.2 Biosimilar Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.2 Biotech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.3 Celgen
2.3.1 Business Overview
2.3.2 Biosimilar Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.2 Celgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.4 Henlius Biotech
2.4.1 Business Overview
2.4.2 Biosimilar Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.2 Henlius Biotech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.5 Amgen
2.5.1 Business Overview
2.5.2 Biosimilar Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.2 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Biosimilar Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.2 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.7 Novartis
2.7.1 Business Overview
2.7.2 Biosimilar Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.2 Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.8 Changchun High Tech
2.8.1 Business Overview
2.8.2 Biosimilar Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.2 Changchun High Tech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
2.9 Innovent
2.9.1 Business Overview
2.9.2 Biosimilar Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.2 Innovent Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share
3 China Biosimilar Drug Market Competition, by Manufacturer
3.1 China Biosimilar Drug Sales and Market Share by Manufacturer
3.2 China Biosimilar Drug Revenue (Value) and Market Share by Manufacturer
3.3 Market Concentration Rate Analysis
3.3.1 Top 3 Biosimilar Drug Manufacturer Market Share
3.3.2 Top 6 Biosimilar Drug Manufacturer Market Share
3.4 Market Competition Trend
4 Biosimilar Drug Market Segment by Type
4.1 China Biosimilar Drug Sales, Revenue and Market Share by Type (2011-2016)
4.1.1 China Biosimilar Drug Sales and Market Share by Type (2011-2016)
4.1.2 China Biosimilar Drug Revenue and Market Share by Type (2011-2016)
4.2 Injection Sales Growth and Price
4.2.1 China Injection Sales Growth (2011-2016)
4.2.2 China Injection Price (2011-2016)
4.3 Tablets Sales Growth and Price
4.3.1 China Tablets Sales Growth (2011-2016)
4.3.2 China Tablets Price (2011-2016)
4.4 Others Sales Growth and Price
4.4.1 China Others Sales Growth (2011-2016)
4.4.2 China Others Price (2011-2016)
4.5 Sales Growth and Price
4.5.1 China Sales Growth (2011-2016)
4.5.2 China Price (2011-2016)
5 China Biosimilar Drug Market Segment by Application
5.1 China Biosimilar Drug Sales Market Share by Application (2011-2016)
5.2 Ankylosing Spondylitis Sales Growth (2011-2016)
5.3 Tumor Sales Growth (2011-2016)
5.4 Rheumatoid Arthrtis Sales Growth (2011-2016)
5.5 Cardiovascular Sales Growth (2011-2016)
5.6 Sales Growth (2011-2016)
5.7 Sales Growth (2011-2016)
6 China Biosimilar Drug Market Forecast (2016-2021)
6.1 China Biosimilar Drug Sales, Revenue (Value) and Growth Rate (2016-2021)
6.2 Biosimilar Drug Market Forecast by Type (2016-2021)
6.3 Biosimilar Drug Market Forecast by Application (2016-2021)
7 Biosimilar Drug Potential Market/Regions except USA
7.1 China Development Status and Outlook
7.1.1 China Biosimilar Drug Sales, Growth Rate and Forecast (2016-2021)
7.1.2 China Biosimilar Drug Revenue (Value), Growth Rate and Forecast (2016-2021)
7.2 Southeast Asia Development Status and Outlook
7.2.1 Southeast Asia Biosimilar Drug Sales, Growth Rate and Forecast (2016-2021)
7.2.2 Southeast Asia Biosimilar Drug Revenue (Value), Growth Rate and Forecast (2016-2021)
7.3 India Development Status and Outlook
7.3.1 India Biosimilar Drug Sales, Growth Rate and Forecast (2016-2021)
7.3.2 India Biosimilar Drug Revenue (Value), Growth Rate and Forecast (2016-2021)
7.4 Latin America Development Status and Outlook
7.4.1 Latin America Biosimilar Drug Sales, Growth Rate and Forecast (2016-2021)
7.4.2 Latin America Biosimilar Drug Revenue (Value), Growth Rate and Forecast (2016-2021)
8 Marketing Strategy Analysis
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
9 Effect Factors of Biosimilar Drug Demand
9.1 Technology Progress
9.2 Consumer Needs Trend/Customer Preference
9.3 External Environmental Change
9.3.1 Technology Progress of Related Industry
9.3.2 External Economic Environment
10 Sales Channel, Distributors, Traders and Dealers
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Future Trend
10.2 Distributors, Traders and Dealers
11 Appendix
11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source
Inquiry For Buying
China Biosimilar Drug
Request Sample
China Biosimilar Drug
